This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
PanX aims to replace addictive benzodiazepines in opioid crisis
Trends in Pharma Development CEO Tom Dooley unveils PanX a new non addictive anti anxiety class using beta blockers and motion sickness agents. The firm holds patent nine six one six zero five two and plans presentations in Washington DC at the Eagle Forum conference. Dr Ashley Benjamin notes success with PanX on difficult patients seeking benzodiazepine alternatives. Dooley cites personal loss of his 24 year old son to opioid death as motivation.
MENTIONED IN THIS ARTICLE
Birmingham
Ula
USA
FDA
Pharma
U.S
Ashley Benjamin
Los Angeles
Benjamin
Tom Dooley
Thomas